| Britta Zoeller Maciuba, | |
|
201 S 5th St, Bardstown, KY 40004-1142 | |
| (502) 348-5968 | |
| Not Available |
| Full Name | Britta Zoeller Maciuba |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 12 Years |
| Location | 201 S 5th St, Bardstown, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225395742 | NPI | - | NPPES |
| 48284 | Other | KY | KBML |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 48284 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vna Health At Home | Louisville, KY | Home health agency |
| Caretenders | Elizabethtown, KY | Home health agency |
| Intrepid Usa Healthcare Services | Elizabethtown, KY | Home health agency |
| Hardin Memorial Hospital | Elizabethtown, KY | Hospital |
| Flaget Memorial Hospital | Bardstown, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Health Medical Group Inc | 5597867184 | 1912 |
| Kentucky Orthopedic Rehabilitation Llc | 0345157293 | 683 |
News Archive
Canada can save lives by implementing powerful health promotion strategies, says Dr. Thomas Farley, the trail-blazing commissioner of the New York City department of health.
Targeting exhausted immune cells may change the prognosis for patients with acute myeloid leukemia (AML) relapse after a stem cell transplant, according to Penn State College of Medicine researchers.
Generally, it is thought that there is a connection between concentrations of ammonia and liver disease, such as fatty liver and cirrhosis, Helicobacter pylori (H. pylori) infection, and kidney failure.
Presbia Coöperatief U.A., an early-stage company focused on surgical solutions for presbyopia, today announced that it will unveil a breakthrough implantable micro-lens treatment for presbyopia at the European Society of Cataract and Refractive Surgery Congress (ESCRS) beginning Sept. 12 in Barcelona.
Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, announced today that the Company has secured approximately $13 million in current and future funding via a registered direct offering and commitments under two separate equity purchase agreements.
› Verified 8 days ago
| Entity Name | Hardin Professional Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306894704 PECOS PAC ID: 9739191628 Enrollment ID: O20060614000061 |
News Archive
Canada can save lives by implementing powerful health promotion strategies, says Dr. Thomas Farley, the trail-blazing commissioner of the New York City department of health.
Targeting exhausted immune cells may change the prognosis for patients with acute myeloid leukemia (AML) relapse after a stem cell transplant, according to Penn State College of Medicine researchers.
Generally, it is thought that there is a connection between concentrations of ammonia and liver disease, such as fatty liver and cirrhosis, Helicobacter pylori (H. pylori) infection, and kidney failure.
Presbia Coöperatief U.A., an early-stage company focused on surgical solutions for presbyopia, today announced that it will unveil a breakthrough implantable micro-lens treatment for presbyopia at the European Society of Cataract and Refractive Surgery Congress (ESCRS) beginning Sept. 12 in Barcelona.
Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, announced today that the Company has secured approximately $13 million in current and future funding via a registered direct offering and commitments under two separate equity purchase agreements.
› Verified 8 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740586213 PECOS PAC ID: 5597867184 Enrollment ID: O20070228000503 |
News Archive
Canada can save lives by implementing powerful health promotion strategies, says Dr. Thomas Farley, the trail-blazing commissioner of the New York City department of health.
Targeting exhausted immune cells may change the prognosis for patients with acute myeloid leukemia (AML) relapse after a stem cell transplant, according to Penn State College of Medicine researchers.
Generally, it is thought that there is a connection between concentrations of ammonia and liver disease, such as fatty liver and cirrhosis, Helicobacter pylori (H. pylori) infection, and kidney failure.
Presbia Coöperatief U.A., an early-stage company focused on surgical solutions for presbyopia, today announced that it will unveil a breakthrough implantable micro-lens treatment for presbyopia at the European Society of Cataract and Refractive Surgery Congress (ESCRS) beginning Sept. 12 in Barcelona.
Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, announced today that the Company has secured approximately $13 million in current and future funding via a registered direct offering and commitments under two separate equity purchase agreements.
› Verified 8 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922401611 PECOS PAC ID: 5597867184 Enrollment ID: O20150219000942 |
News Archive
Canada can save lives by implementing powerful health promotion strategies, says Dr. Thomas Farley, the trail-blazing commissioner of the New York City department of health.
Targeting exhausted immune cells may change the prognosis for patients with acute myeloid leukemia (AML) relapse after a stem cell transplant, according to Penn State College of Medicine researchers.
Generally, it is thought that there is a connection between concentrations of ammonia and liver disease, such as fatty liver and cirrhosis, Helicobacter pylori (H. pylori) infection, and kidney failure.
Presbia Coöperatief U.A., an early-stage company focused on surgical solutions for presbyopia, today announced that it will unveil a breakthrough implantable micro-lens treatment for presbyopia at the European Society of Cataract and Refractive Surgery Congress (ESCRS) beginning Sept. 12 in Barcelona.
Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, announced today that the Company has secured approximately $13 million in current and future funding via a registered direct offering and commitments under two separate equity purchase agreements.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Britta Zoeller Maciuba, 201 S 5th St, Bardstown, KY 40004-1142 Ph: () - | Britta Zoeller Maciuba, 201 S 5th St, Bardstown, KY 40004-1142 Ph: (502) 348-5968 |
News Archive
Canada can save lives by implementing powerful health promotion strategies, says Dr. Thomas Farley, the trail-blazing commissioner of the New York City department of health.
Targeting exhausted immune cells may change the prognosis for patients with acute myeloid leukemia (AML) relapse after a stem cell transplant, according to Penn State College of Medicine researchers.
Generally, it is thought that there is a connection between concentrations of ammonia and liver disease, such as fatty liver and cirrhosis, Helicobacter pylori (H. pylori) infection, and kidney failure.
Presbia Coöperatief U.A., an early-stage company focused on surgical solutions for presbyopia, today announced that it will unveil a breakthrough implantable micro-lens treatment for presbyopia at the European Society of Cataract and Refractive Surgery Congress (ESCRS) beginning Sept. 12 in Barcelona.
Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, announced today that the Company has secured approximately $13 million in current and future funding via a registered direct offering and commitments under two separate equity purchase agreements.
› Verified 8 days ago
William Lawrence Hagan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 S 5th St, Bardstown, KY 40004 Phone: 502-348-5968 Fax: 502-349-0963 | |
Hugh Hall Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 703 Mcdowell Blvd, Suite 100, Bardstown, KY 40004 Phone: 502-349-1212 Fax: 502-349-1216 | |
Mrs. Lida Miller Oxnard, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 809 Morton Ave Ste 200, Suite 200, Bardstown, KY 40004 Phone: 502-331-0411 Fax: 502-331-0380 | |
Mark Allan Abramovich, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 W John Fitch Ave, Suite 210, Bardstown, KY 40004 Phone: 502-348-7648 Fax: 502-348-7490 | |
Jacob William Vincent, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3615 E John Rowan Blvd Ste 104, Bardstown, KY 40004 Phone: 502-348-5968 Fax: 270-706-5802 | |
Matthew Abel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3615 E John Rowan Blvd Ste 104, Bardstown, KY 40004 Phone: 502-348-5968 Fax: 270-706-5802 |